76. 下垂体性ゴナドトロピン分泌亢進症 Pituitary gonadotropin secretion hyperthyroidism Clinical trials / Disease details

臨床試験数 : 29 / 薬物数 : 44 - (DrugBank : 14) / 標的遺伝子数 : 5 - 標的パスウェイ数 : 15

18 trials found

diseases per page:

Showing 1 to 10 of 18 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05341115 (ClinicalTrials.gov)	March 20, 2023	18/4/2022	A Study of Leuprolide Acetate Depot in Children With Central Precocious Puberty	An Open Label, Multicenter, Single-arm and Prospective Study to Assess the Efficacy and Safety of Le ...	Central Precocious Puberty	Drug: Leuprorelin Acetate Depot 3M	Takeda	NULL	Not yet recruiting	N/A	9 Years	All	80	Phase 4	China
2	NCT03963752 (ClinicalTrials.gov)	August 15, 2019	22/5/2019	Clinical Trial of Rapid Progressive Central Precocious Puberty With Integrative Chinese and Western ...	Evidence-based Medical Research on the Treatment of Children's Rapid Progressive Central Precocious ...	Idiopathic Precocious Puberty	Drug: Ziyinxiehuo Granules Herbs;Drug: Megestrol Acetate Tablet;Drug: Leuprorelin Acetate 3.75mg Injec ...	Children's Hospital of Fudan University	NULL	Recruiting	5 Years	8 Years	Female	164	Phase 4	China
3	NCT03695237 (ClinicalTrials.gov)	October 24, 2018	2/10/2018	A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of LeuprolideAcetate 45 ...	A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetic ...	Central Precocious Puberty (CPP)	Drug: Leuprolide Acetate (LA)	AbbVie	NULL	Active, not recruiting	2 Years	11 Years	All	45	Phase 3	United States;Puerto Rico
4	NCT02993926 (ClinicalTrials.gov)	June 24, 2017	13/12/2016	A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (C ...	An Observational, Retrospective Study to Evaluate the Long Term Safety and Effectiveness of Leuprore ...	Central Precocious Puberty	Drug: Enantone;Drug: GnRH agonist	Takeda	NULL	Completed	N/A	N/A	All	108		China
5	NCT02974270 (ClinicalTrials.gov)	June 2016	19/5/2016	Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate	Analysis of Body Mass Index in Central Precocious Puberty(CPP) Patients Treated With LeuprolideAceta ...	Precocious Puberty, Central	Drug: Leuprolide	Kyungpook National University	NULL	Recruiting	N/A	9 Years	Both	100	Phase 4	Korea, Republic of
6	NCT02811471 (ClinicalTrials.gov)	June 2016	21/6/2016	Pharmacokinetic Study of LeuprolideAcetate Injectable Suspension in the Treatment of Central Precoci ...	An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leupro ...	Central Precocious Puberty	Drug: Leuprolide	Nemours Children's Clinic	Tolmar Inc.	Recruiting	2 Years	9 Years	Both	5	Phase 3	United States
7	NCT02452931 (ClinicalTrials.gov)	August 31, 2015	5/5/2015	Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty	An Open-label, Single Arm, Multicenter Study on the Efficacy, Safety, and Pharmacokinetics of Leupro ...	Precocious Puberty, Central	Drug: Leuprolide Acetate 45 mg	Tolmar Inc.	NULL	Completed	2 Years	9 Years	All	64	Phase 3	United States;Argentina;Canada;Chile;Mexico;New Zealand
8	NCT02427958 (ClinicalTrials.gov)	August 7, 2015	23/4/2015	A Study to Assess the Safety and Efficacy of Leuprorelinin Central Precocious Puberty in Chinese Par ...	An Open Label, Multicenter Study to Assess the Safety and Efficacy of Leuprorelinin the Treatment of ...	Central Precocious Puberty	Drug: Leuprorelin	Takeda	NULL	Completed	1 Year	9 Years	All	307	Phase 4	China
9	NCT03316482 (ClinicalTrials.gov)	June 11, 2015	12/10/2017	LeuprorelinAcetate DPS (Leuplin DPS) Treatment Quarterly in Patients With Central Precocious Puberty ...	A Multicenter, Open, Prospective Study to Evaluate the Safety and Efficacy of LeuprorelinAcetate DPS ...	Central Precocious Puberty	Drug: Leuplin DPS 11.25mg	Jin Soon Hwang	NULL	Completed	4 Years	9 Years	All	58	Phase 4	Korea, Republic of
10	NCT02920515 (ClinicalTrials.gov)	September 2012	16/8/2016	Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty	Multi-site Study of Comprehensive Treatment for Children Precocious Puberty	Central Precocious Puberty	Drug: Triptorlin or Leuprorelin;Drug: Zhibo dihuang pills;Drug: Dabu ying pills	Ruijin Hospital	Shanghai Children's Hospital;Shanghai Children's Medical Center;Xin Hua Hospital;Shanghai Children's ...	Completed	2 Years	14 Years	Female	740	Phase 4	NULL

First Previous1 2Next Last